BridgeBio Pharma, Inc. Form 13F Holdings: Bonds and Notes
The company's notes and bonds as institutional managers listed them on Form 13F, by quarter and CUSIP. Most corporate bonds are not 13F securities, so few managers report them. Class, amount and value are as filed.
- 2026-06-30: CUSIP 10806XAB8; Class as filed NOTE 2.500% 3/1; Managers 6; Principal or shares as filed 9,041,000.
- 2026-06-30: CUSIP 10806XAJ1; Class as filed NOTE 1.750% 3/0; Managers 3; Principal or shares as filed 4,200,227.
- 2026-06-30: CUSIP 10806XAD4; Class as filed NOTE 2.250% 2/0; Managers 4; Principal or shares as filed 1,518,000.
- 2026-03-31: CUSIP 10806XAB8; Class as filed NOTE 2.500% 3/1; Managers 7; Principal or shares as filed 3,464,145.
| Quarter end | CUSIP | Class as filed | Managers | Principal or shares as filed | Value (USD) |
|---|
| 2026-06-30 | 10806XAB8 | NOTE 2.500% 3/1 | 6 | 9,041,000 | $67,033,030.00 |
|---|
| 2026-06-30 | 10806XAJ1 | NOTE 1.750% 3/0 | 3 | 4,200,227 | $7,448,189.00 |
|---|
| 2026-06-30 | 10806XAD4 | NOTE 2.250% 2/0 | 4 | 1,518,000 | $1,684,149.00 |
|---|
| 2026-03-31 | 10806XAB8 | NOTE 2.500% 3/1 | 7 | 3,464,145 | $54,463,208.00 |
|---|
| 2026-03-31 | 10806XAJ1 | NOTE 1.750% 3/0 | 4 | 7,584,000 | $30,993,458.00 |
|---|
| 2026-03-31 | 10806XAD4 | NOTE 2.250% 2/0 | 7 | 10,110,000 | $11,338,144.00 |
|---|
| 2025-12-31 | 10806XAD4 | NOTE 2.250% 2/0 | 5 | 28,404,000 | $29,166,702.00 |
|---|
| 2025-12-31 | 10806XAB8 | NOTE 2.500% 3/1 | 9 | 6,530,348 | $6,575,289.00 |
|---|
| 2025-09-30 | 10806XAB8 | NOTE 2.500% 3/1 | 6 | 3,606,702 | $19,949,583.00 |
|---|
| 2025-09-30 | 10806XAD4 | NOTE 2.250% 2/0 | 4 | 5,830,000 | $3,281,589.00 |
|---|
| 2025-06-30 | 10806XAB8 | NOTE 2.500% 3/1 | 6 | 60,930,135 | $96,645,028.00 |
|---|
| 2025-06-30 | 10806XAD4 | NOTE 2.250% 2/0 | 6 | 10,041,000 | $4,185,814.00 |
|---|
| 2025-03-31 | 10806XAD4 | NOTE 2.250% 2/0 | 6 | 9,773,999 | $3,953,217.00 |
|---|
| 2025-03-31 | 10806XAB8 | Corporate Debt | 3 | 301,000 | $344,463.00 |
|---|
| 2024-12-31 | 10806XAD4 | NOTE 2.250% 2/0 | 4 | 4,656,000 | $2,628,635.00 |
|---|
| 2024-12-31 | 10806XAB8 | NOTE 2.500% 3/1 | 6 | 5,967,000 | $880,382.00 |
|---|
| 2024-09-30 | 10806XAD4 | NOTE 2.250% 2/0 | 5 | 7,593,000 | $2,416,890.00 |
|---|
| 2024-09-30 | 10806XAB8 | NOTE 2.500% 3/1 | 4 | 5,355,000 | $550,326.00 |
|---|
| 2024-06-30 | 10806XAB8 | NOTE 2.500% 3/1 | 5 | 9,003,000 | $6,111,867.00 |
|---|
| 2024-06-30 | 10806XAD4 | NOTE 2.250% 2/0 | 6 | 6,317,000 | $707,286.00 |
|---|
| 2024-03-31 | 10806XAB8 | NOTE 2.500% 3/1 | 5 | 6,085,000 | $636,065.00 |
|---|
| 2024-03-31 | 10806XAD4 | NOTE 2.250% 2/0 | 5 | 18,476,000 | $142,018.00 |
|---|
| 2023-12-31 | 10806XAB8 | CONV. NOTE | 8 | 19,581,000 | $4,945,733.00 |
|---|
| 2023-12-31 | 10806XAD4 | NOTE 2.250% 2/0 | 6 | 21,611,000 | $4,479,024.00 |
|---|